BMPR2 and chronic thromboembolic pulmonary hypertension: Upregulation or downregulation of the genes such as those responsible for the expression of interleukin-8, bone morphogenetic protein type 2 receptor (BMPR2), and polymorphism of angiotensin-converting enzyme gene have been described as contributing factors for CTEPH [21,22].